KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GoodRx Holdings (GDRX) Equity Ratio (2019 - 2025)

Historic Equity Ratio for GoodRx Holdings (GDRX) over the last 7 years, with Q3 2025 value amounting to 0.45.

  • GoodRx Holdings' Equity Ratio fell 1183.54% to 0.45 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.45, marking a year-over-year decrease of 1183.54%. This contributed to the annual value of 0.52 for FY2024, which is 885.81% up from last year.
  • Latest data reveals that GoodRx Holdings reported Equity Ratio of 0.45 as of Q3 2025, which was down 1183.54% from 0.49 recorded in Q2 2025.
  • GoodRx Holdings' Equity Ratio's 5-year high stood at 0.53 during Q2 2023, with a 5-year trough of 0.43 in Q1 2024.
  • Over the past 5 years, GoodRx Holdings' median Equity Ratio value was 0.51 (recorded in 2022), while the average stood at 0.5.
  • In the last 5 years, GoodRx Holdings' Equity Ratio tumbled by 1547.16% in 2024 and then soared by 1639.22% in 2025.
  • GoodRx Holdings' Equity Ratio (Quarter) stood at 0.52 in 2021, then fell by 1.84% to 0.51 in 2022, then dropped by 5.56% to 0.48 in 2023, then grew by 8.86% to 0.52 in 2024, then dropped by 13.19% to 0.45 in 2025.
  • Its Equity Ratio was 0.45 in Q3 2025, compared to 0.49 in Q2 2025 and 0.51 in Q1 2025.